E815
TEAS SECTION 8 & 15 RECEIVED
07/08/2026
Back to search
Official data from USPTO
NEXT DOSE PHARMACY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NEXT DOSE PHARMACY
ST13
US500000088517314Class
35
Filing
88517314
Registration
6217688
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
07/09/2026
Trademark type
Word
Nice classes
35
Filing date
07/16/2019
Registration date
12/08/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/08/2020
Last transaction
07/09/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/11/2017
First use in commerce
06/10/2020
Drawing code
4
Owner type
16
Owner location
Tampa, FL, US
Examiner
GAGLIARDI, JEANINE
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Rightback LLC
Representatives
Daniel G. Musca LEXIUM PLLC
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Retail pharmacy services
Publications
History of USPTO decisions and trademark events.
34 publications found
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/08/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
12/08/2020
DOCK
ASSIGNED TO EXAMINER
11/02/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/31/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/31/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/30/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/30/2020
EX1G
SOU EXTENSION 1 GRANTED
10/30/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/28/2020
NREV
NOTICE OF REVIVAL - E-MAILED
09/18/2020
IUAF
USE AMENDMENT FILED
09/17/2020
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
09/17/2020
PETG
PETITION TO REVIVE-GRANTED
09/17/2020
PROA
TEAS PETITION TO REVIVE RECEIVED
09/17/2020
EISU
TEAS STATEMENT OF USE RECEIVED
09/17/2020
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
09/08/2020
ABN6
ABANDONMENT - NO USE STATEMENT FILED
09/07/2020
EXT1
SOU EXTENSION 1 FILED
08/04/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/04/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/10/2019
PUBO
PUBLISHED FOR OPPOSITION
12/10/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/20/2019
ALIE
ASSIGNED TO LIE
11/05/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/30/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/29/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/28/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/28/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/08/2019
GNRT
NON-FINAL ACTION E-MAILED
10/08/2019
CNRT
NON-FINAL ACTION WRITTEN
10/08/2019
DOCK
ASSIGNED TO EXAMINER
10/02/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/23/2019
NWAP
NEW APPLICATION ENTERED
07/19/2019
Continuous trademark protection
Get notified about every new filing that threatens NEXT DOSE PHARMACY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.